ADMA Biologics, Inc. (ADMA)

9.72 -0.21 (-2.11%) USD  |  NASDAQ  |  Oct 02, 16:00
9.72 0.00 (0.00%) After-Hours: 20:00
More

ADMA Biologics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
March 11, 2026 --
December 24, 2024 --
Date Value
October 28, 2024 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Vericel Corp. --
BioMarin Pharmaceutical, Inc. Upgrade
Emergent BioSolutions, Inc. Upgrade
Exelixis, Inc. Upgrade
Akebia Therapeutics, Inc. --